Stryker Corporation (NYSE: SYK) Stock Competitors & Peer Comparison
See SYK's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for SYK and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SYK | $274.19 | -0.34% | 105.1B | 20.47 | $13.39 | +1.27% |
| ABT | $102.98 | +0.36% | 178.2B | 19.76 | $5.21 | +2.40% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| MDT | $91.75 | -0.41% | 117.4B | 16.59 | $5.53 | +3.10% |
| BSX | $43.72 | +0.88% | 65B | 14.11 | $3.10 | N/A |
| EW | $88.34 | +0.09% | 50.9B | 32.71 | $2.70 | N/A |
| DXCM | $89.17 | -0.20% | 33.6B | 34.97 | $2.55 | N/A |
| GEHC | $64.81 | +1.06% | 29.3B | 14.21 | $4.56 | +0.22% |
| PHG | $24.90 | +0.89% | 24.3B | 14.23 | $1.75 | +3.97% |
| ZBH | $94.32 | -1.09% | 18.2B | 11.12 | $8.48 | +1.02% |
Stock Comparison
Abbott Laboratories (NYSE: ABT)
SYK vs ABT Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, ABT has a market cap of 178.2B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while ABT trades at $102.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas ABT's P/E ratio is 19.76. In terms of profitability, SYK's ROE is +0.16%, compared to ABT's ROE of +0.11%. Regarding short-term risk, SYK is more volatile compared to ABT. This indicates higher risk in terms of short-term price fluctuations for SYK.Check ABT's competition here
Boston Scientific Corporation (NYSE: BSX-PA)
SYK vs BSX-PA Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, SYK's ROE is +0.16%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, SYK is less volatile compared to BSX-PA. This indicates lower risk in terms of short-term price fluctuations for SYK.Check BSX-PA's competition here
Medtronic plc (NYSE: MDT)
SYK vs MDT Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, MDT has a market cap of 117.4B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while MDT trades at $91.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas MDT's P/E ratio is 16.59. In terms of profitability, SYK's ROE is +0.16%, compared to MDT's ROE of +0.11%. Regarding short-term risk, SYK is more volatile compared to MDT. This indicates higher risk in terms of short-term price fluctuations for SYK.Check MDT's competition here
Boston Scientific Corporation (NYSE: BSX)
SYK vs BSX Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, BSX has a market cap of 65B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while BSX trades at $43.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas BSX's P/E ratio is 14.11. In terms of profitability, SYK's ROE is +0.16%, compared to BSX's ROE of +0.15%. Regarding short-term risk, SYK is less volatile compared to BSX. This indicates lower risk in terms of short-term price fluctuations for SYK.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
SYK vs EW Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, EW has a market cap of 50.9B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while EW trades at $88.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas EW's P/E ratio is 32.71. In terms of profitability, SYK's ROE is +0.16%, compared to EW's ROE of +0.10%. Regarding short-term risk, SYK is more volatile compared to EW. This indicates higher risk in terms of short-term price fluctuations for SYK.Check EW's competition here
DexCom, Inc. (NASDAQ: DXCM)
SYK vs DXCM Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, DXCM has a market cap of 33.6B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while DXCM trades at $89.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas DXCM's P/E ratio is 34.97. In terms of profitability, SYK's ROE is +0.16%, compared to DXCM's ROE of +0.36%. Regarding short-term risk, SYK is more volatile compared to DXCM. This indicates higher risk in terms of short-term price fluctuations for SYK.Check DXCM's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
SYK vs GEHC Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, GEHC has a market cap of 29.3B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while GEHC trades at $64.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas GEHC's P/E ratio is 14.21. In terms of profitability, SYK's ROE is +0.16%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, SYK is less volatile compared to GEHC. This indicates lower risk in terms of short-term price fluctuations for SYK.Check GEHC's competition here
Koninklijke Philips N.V. (NYSE: PHG)
SYK vs PHG Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, PHG has a market cap of 24.3B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while PHG trades at $24.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas PHG's P/E ratio is 14.23. In terms of profitability, SYK's ROE is +0.16%, compared to PHG's ROE of +0.10%. Regarding short-term risk, SYK is more volatile compared to PHG. This indicates higher risk in terms of short-term price fluctuations for SYK.Check PHG's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
SYK vs ZBH Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, ZBH has a market cap of 18.2B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while ZBH trades at $94.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas ZBH's P/E ratio is 11.12. In terms of profitability, SYK's ROE is +0.16%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, SYK is less volatile compared to ZBH. This indicates lower risk in terms of short-term price fluctuations for SYK.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
SYK vs ABMD Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas ABMD's P/E ratio is 65.36. In terms of profitability, SYK's ROE is +0.16%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, SYK is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for SYK.Check ABMD's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
SYK vs SWAV Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas SWAV's P/E ratio is 78.76. In terms of profitability, SYK's ROE is +0.16%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, SYK is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for SYK.Check SWAV's competition here
Penumbra, Inc. (NYSE: PEN)
SYK vs PEN Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, PEN has a market cap of 12.6B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while PEN trades at $318.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas PEN's P/E ratio is 83.23. In terms of profitability, SYK's ROE is +0.16%, compared to PEN's ROE of +0.11%. Regarding short-term risk, SYK is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for SYK.Check PEN's competition here
Smith & Nephew plc (NYSE: SNN)
SYK vs SNN Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, SNN has a market cap of 11.6B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while SNN trades at $27.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas SNN's P/E ratio is 18.68. In terms of profitability, SYK's ROE is +0.16%, compared to SNN's ROE of +0.12%. Regarding short-term risk, SYK is more volatile compared to SNN. This indicates higher risk in terms of short-term price fluctuations for SYK.Check SNN's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
SYK vs BIO-B Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, BIO-B has a market cap of 10.6B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while BIO-B trades at $385.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas BIO-B's P/E ratio is -67.94. In terms of profitability, SYK's ROE is +0.16%, compared to BIO-B's ROE of +0.03%. Regarding short-term risk, SYK is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for SYK.Check BIO-B's competition here
Align Technology, Inc. (NASDAQ: ALGN)
SYK vs ALGN Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, ALGN has a market cap of 10.5B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while ALGN trades at $146.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas ALGN's P/E ratio is 13.39. In terms of profitability, SYK's ROE is +0.16%, compared to ALGN's ROE of +0.10%. Regarding short-term risk, SYK is less volatile compared to ALGN. This indicates lower risk in terms of short-term price fluctuations for SYK.Check ALGN's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
SYK vs BIO Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, BIO has a market cap of 10.2B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while BIO trades at $377.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas BIO's P/E ratio is 40.66. In terms of profitability, SYK's ROE is +0.16%, compared to BIO's ROE of +0.03%. Regarding short-term risk, SYK is less volatile compared to BIO. This indicates lower risk in terms of short-term price fluctuations for SYK.Check BIO's competition here
Globus Medical, Inc. (NYSE: GMED)
SYK vs GMED Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, GMED has a market cap of 10B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while GMED trades at $74.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas GMED's P/E ratio is 16.73. In terms of profitability, SYK's ROE is +0.16%, compared to GMED's ROE of +0.12%. Regarding short-term risk, SYK is more volatile compared to GMED. This indicates higher risk in terms of short-term price fluctuations for SYK.Check GMED's competition here
Insulet Corp. (NASDAQ: PODD)
SYK vs PODD Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, PODD has a market cap of 9.7B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while PODD trades at $140.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas PODD's P/E ratio is 23.96. In terms of profitability, SYK's ROE is +0.16%, compared to PODD's ROE of +0.27%. Regarding short-term risk, SYK is less volatile compared to PODD. This indicates lower risk in terms of short-term price fluctuations for SYK.Check PODD's competition here
Glaukos Corporation (NYSE: GKOS)
SYK vs GKOS Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, GKOS has a market cap of 9.5B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while GKOS trades at $161.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas GKOS's P/E ratio is -187.77. In terms of profitability, SYK's ROE is +0.16%, compared to GKOS's ROE of -0.27%. Regarding short-term risk, SYK is less volatile compared to GKOS. This indicates lower risk in terms of short-term price fluctuations for SYK.Check GKOS's competition here
Masimo Corporation (NASDAQ: MASI)
SYK vs MASI Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas MASI's P/E ratio is 44.43. In terms of profitability, SYK's ROE is +0.16%, compared to MASI's ROE of +0.09%. Regarding short-term risk, SYK is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for SYK.Check MASI's competition here
Bruker Corporation (NASDAQ: BRKR)
SYK vs BRKR Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, BRKR has a market cap of 9.4B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while BRKR trades at $61.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas BRKR's P/E ratio is 30.94. In terms of profitability, SYK's ROE is +0.16%, compared to BRKR's ROE of -0.03%. Regarding short-term risk, SYK is less volatile compared to BRKR. This indicates lower risk in terms of short-term price fluctuations for SYK.Check BRKR's competition here
Bruker Corporation (NASDAQ: BRKRP)
SYK vs BRKRP Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, BRKRP has a market cap of 9.1B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while BRKRP trades at $456.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas BRKRP's P/E ratio is 246.51. In terms of profitability, SYK's ROE is +0.16%, compared to BRKRP's ROE of -0.03%. Regarding short-term risk, SYK is more volatile compared to BRKRP. This indicates higher risk in terms of short-term price fluctuations for SYK.Check BRKRP's competition here
Haemonetics Corporation (NYSE: HAE)
SYK vs HAE Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, HAE has a market cap of 4.9B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while HAE trades at $108.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas HAE's P/E ratio is 21.70. In terms of profitability, SYK's ROE is +0.16%, compared to HAE's ROE of +0.11%. Regarding short-term risk, SYK is less volatile compared to HAE. This indicates lower risk in terms of short-term price fluctuations for SYK.Check HAE's competition here
Inari Medical, Inc. (NASDAQ: NARI)
SYK vs NARI Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas NARI's P/E ratio is -59.24. In terms of profitability, SYK's ROE is +0.16%, compared to NARI's ROE of -0.00%. Regarding short-term risk, SYK is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for SYK.Check NARI's competition here
LivaNova PLC (NASDAQ: LIVN)
SYK vs LIVN Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, LIVN has a market cap of 4.3B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while LIVN trades at $78.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas LIVN's P/E ratio is 18.57. In terms of profitability, SYK's ROE is +0.16%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, SYK is less volatile compared to LIVN. This indicates lower risk in terms of short-term price fluctuations for SYK.Check LIVN's competition here
Integer Holdings Corporation (NYSE: ITGR)
SYK vs ITGR Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, ITGR has a market cap of 4.3B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while ITGR trades at $126.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas ITGR's P/E ratio is 19.90. In terms of profitability, SYK's ROE is +0.16%, compared to ITGR's ROE of +0.07%. Regarding short-term risk, SYK is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for SYK.Check ITGR's competition here
Axonics, Inc. (NASDAQ: AXNX)
SYK vs AXNX Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas AXNX's P/E ratio is -709.80. In terms of profitability, SYK's ROE is +0.16%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, SYK is more volatile compared to AXNX. This indicates higher risk in terms of short-term price fluctuations for SYK.Check AXNX's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
SYK vs IRTC Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, IRTC has a market cap of 3.6B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while IRTC trades at $110.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas IRTC's P/E ratio is -256.70. In terms of profitability, SYK's ROE is +0.16%, compared to IRTC's ROE of -0.09%. Regarding short-term risk, SYK is less volatile compared to IRTC. This indicates lower risk in terms of short-term price fluctuations for SYK.Check IRTC's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
SYK vs TMDX Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, TMDX has a market cap of 3B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while TMDX trades at $87.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas TMDX's P/E ratio is 44.31. In terms of profitability, SYK's ROE is +0.16%, compared to TMDX's ROE of +0.33%. Regarding short-term risk, SYK is less volatile compared to TMDX. This indicates lower risk in terms of short-term price fluctuations for SYK.Check TMDX's competition here
Neogen Corporation (NASDAQ: NEOG)
SYK vs NEOG Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, NEOG has a market cap of 3B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while NEOG trades at $13.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas NEOG's P/E ratio is 48.61. In terms of profitability, SYK's ROE is +0.16%, compared to NEOG's ROE of -0.00%. Regarding short-term risk, SYK is less volatile compared to NEOG. This indicates lower risk in terms of short-term price fluctuations for SYK.Check NEOG's competition here
AxoGen, Inc. (NASDAQ: AXGN)
SYK vs AXGN Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, AXGN has a market cap of 2.5B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while AXGN trades at $45.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas AXGN's P/E ratio is 120.87. In terms of profitability, SYK's ROE is +0.16%, compared to AXGN's ROE of -0.18%. Regarding short-term risk, SYK is less volatile compared to AXGN. This indicates lower risk in terms of short-term price fluctuations for SYK.Check AXGN's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
SYK vs INSP Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, INSP has a market cap of 2.2B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while INSP trades at $75.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas INSP's P/E ratio is 33.33. In terms of profitability, SYK's ROE is +0.16%, compared to INSP's ROE of +0.18%. Regarding short-term risk, SYK is less volatile compared to INSP. This indicates lower risk in terms of short-term price fluctuations for SYK.Check INSP's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
SYK vs UFPT Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, UFPT has a market cap of 2.2B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while UFPT trades at $281.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas UFPT's P/E ratio is 28.77. In terms of profitability, SYK's ROE is +0.16%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, SYK is less volatile compared to UFPT. This indicates lower risk in terms of short-term price fluctuations for SYK.Check UFPT's competition here
Butterfly Network, Inc. (NYSE: BFLY)
SYK vs BFLY Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, BFLY has a market cap of 2.2B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while BFLY trades at $8.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas BFLY's P/E ratio is -33.98. In terms of profitability, SYK's ROE is +0.16%, compared to BFLY's ROE of -0.38%. Regarding short-term risk, SYK is less volatile compared to BFLY. This indicates lower risk in terms of short-term price fluctuations for SYK.Check BFLY's competition here
NuVasive, Inc. (NASDAQ: NUVA)
SYK vs NUVA Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas NUVA's P/E ratio is 75.00. In terms of profitability, SYK's ROE is +0.16%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, SYK is less volatile compared to NUVA. This indicates lower risk in terms of short-term price fluctuations for SYK.Check NUVA's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
SYK vs ESTA Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, ESTA has a market cap of 2B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while ESTA trades at $67.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas ESTA's P/E ratio is -53.76. In terms of profitability, SYK's ROE is +0.16%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, SYK is less volatile compared to ESTA. This indicates lower risk in terms of short-term price fluctuations for SYK.Check ESTA's competition here
Novocure Ltd (NASDAQ: NVCR)
SYK vs NVCR Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, NVCR has a market cap of 1.9B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while NVCR trades at $16.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas NVCR's P/E ratio is -12.72. In terms of profitability, SYK's ROE is +0.16%, compared to NVCR's ROE of -0.44%. Regarding short-term risk, SYK is less volatile compared to NVCR. This indicates lower risk in terms of short-term price fluctuations for SYK.Check NVCR's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
SYK vs ATEC Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, ATEC has a market cap of 1.6B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while ATEC trades at $10.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas ATEC's P/E ratio is -169.50. In terms of profitability, SYK's ROE is +0.16%, compared to ATEC's ROE of -8.19%. Regarding short-term risk, SYK is less volatile compared to ATEC. This indicates lower risk in terms of short-term price fluctuations for SYK.Check ATEC's competition here
CONMED Corporation (NYSE: CNMD)
SYK vs CNMD Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, CNMD has a market cap of 1.3B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while CNMD trades at $44.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas CNMD's P/E ratio is 9.82. In terms of profitability, SYK's ROE is +0.16%, compared to CNMD's ROE of +0.06%. Regarding short-term risk, SYK is less volatile compared to CNMD. This indicates lower risk in terms of short-term price fluctuations for SYK.Check CNMD's competition here
Heska Corporation (NASDAQ: HSKA)
SYK vs HSKA Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas HSKA's P/E ratio is -62.49. In terms of profitability, SYK's ROE is +0.16%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, SYK is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for SYK.Check HSKA's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
SYK vs IART Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, IART has a market cap of 1.2B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while IART trades at $15.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas IART's P/E ratio is 6.61. In terms of profitability, SYK's ROE is +0.16%, compared to IART's ROE of -0.01%. Regarding short-term risk, SYK is less volatile compared to IART. This indicates lower risk in terms of short-term price fluctuations for SYK.Check IART's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
SYK vs TNDM Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, TNDM has a market cap of 1.2B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while TNDM trades at $17.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas TNDM's P/E ratio is -18.95. In terms of profitability, SYK's ROE is +0.16%, compared to TNDM's ROE of -0.46%. Regarding short-term risk, SYK is less volatile compared to TNDM. This indicates lower risk in terms of short-term price fluctuations for SYK.Check TNDM's competition here
Avanos Medical, Inc. (NYSE: AVNS)
SYK vs AVNS Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas AVNS's P/E ratio is 27.77. In terms of profitability, SYK's ROE is +0.16%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, SYK is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for SYK.Check AVNS's competition here
Artivion, Inc. (NYSE: AORT)
SYK vs AORT Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, AORT has a market cap of 1.1B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while AORT trades at $23.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas AORT's P/E ratio is 39.40. In terms of profitability, SYK's ROE is +0.16%, compared to AORT's ROE of -0.01%. Regarding short-term risk, SYK is less volatile compared to AORT. This indicates lower risk in terms of short-term price fluctuations for SYK.Check AORT's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
SYK vs SILK Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas SILK's P/E ratio is -18.96. In terms of profitability, SYK's ROE is +0.16%, compared to SILK's ROE of -0.35%. Regarding short-term risk, SYK is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for SYK.Check SILK's competition here
Paragon 28, Inc. (NYSE: FNA)
SYK vs FNA Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas FNA's P/E ratio is -19.83. In terms of profitability, SYK's ROE is +0.16%, compared to FNA's ROE of -0.35%. Regarding short-term risk, SYK is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for SYK.Check FNA's competition here
IRadimed Corporation (NASDAQ: IRMD)
SYK vs IRMD Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, IRMD has a market cap of 1.1B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while IRMD trades at $82.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas IRMD's P/E ratio is 41.44. In terms of profitability, SYK's ROE is +0.16%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, SYK is more volatile compared to IRMD. This indicates higher risk in terms of short-term price fluctuations for SYK.Check IRMD's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
SYK vs PRCT Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, PRCT has a market cap of 1.1B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while PRCT trades at $18.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas PRCT's P/E ratio is -9.54. In terms of profitability, SYK's ROE is +0.16%, compared to PRCT's ROE of -0.31%. Regarding short-term risk, SYK is less volatile compared to PRCT. This indicates lower risk in terms of short-term price fluctuations for SYK.Check PRCT's competition here
Enovis Corporation (NYSE: ENOV)
SYK vs ENOV Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, ENOV has a market cap of 1B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while ENOV trades at $18.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas ENOV's P/E ratio is 5.17. In terms of profitability, SYK's ROE is +0.16%, compared to ENOV's ROE of -0.68%. Regarding short-term risk, SYK is less volatile compared to ENOV. This indicates lower risk in terms of short-term price fluctuations for SYK.Check ENOV's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
SYK vs LMRI Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, LMRI has a market cap of 1B. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while LMRI trades at $10.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas LMRI's P/E ratio is -20.78. In terms of profitability, SYK's ROE is +0.16%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, SYK is less volatile compared to LMRI. This indicates lower risk in terms of short-term price fluctuations for SYK.Check LMRI's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
SYK vs BBNX Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, BBNX has a market cap of 991.6M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while BBNX trades at $22.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas BBNX's P/E ratio is -13.36. In terms of profitability, SYK's ROE is +0.16%, compared to BBNX's ROE of -0.26%. Regarding short-term risk, SYK is less volatile compared to BBNX. This indicates lower risk in terms of short-term price fluctuations for SYK.Check BBNX's competition here
CeriBell, Inc. (NASDAQ: CBLL)
SYK vs CBLL Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, CBLL has a market cap of 920.1M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while CBLL trades at $24.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas CBLL's P/E ratio is -13.78. In terms of profitability, SYK's ROE is +0.16%, compared to CBLL's ROE of -0.45%. Regarding short-term risk, SYK is less volatile compared to CBLL. This indicates lower risk in terms of short-term price fluctuations for SYK.Check CBLL's competition here
Bioventus Inc. (NASDAQ: BVS)
SYK vs BVS Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, BVS has a market cap of 901.7M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while BVS trades at $13.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas BVS's P/E ratio is 17.51. In terms of profitability, SYK's ROE is +0.16%, compared to BVS's ROE of +0.28%. Regarding short-term risk, SYK is less volatile compared to BVS. This indicates lower risk in terms of short-term price fluctuations for SYK.Check BVS's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
SYK vs CSII Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, CSII has a market cap of 844M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas CSII's P/E ratio is -20.83. In terms of profitability, SYK's ROE is +0.16%, compared to CSII's ROE of -0.14%. Regarding short-term risk, SYK is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for SYK.Check CSII's competition here
InMode Ltd. (NASDAQ: INMD)
SYK vs INMD Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, INMD has a market cap of 833.5M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while INMD trades at $14.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas INMD's P/E ratio is 10.07. In terms of profitability, SYK's ROE is +0.16%, compared to INMD's ROE of +0.12%. Regarding short-term risk, SYK is more volatile compared to INMD. This indicates higher risk in terms of short-term price fluctuations for SYK.Check INMD's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
SYK vs SIBN Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, SIBN has a market cap of 818.2M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while SIBN trades at $18.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas SIBN's P/E ratio is -54.26. In terms of profitability, SYK's ROE is +0.16%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, SYK is less volatile compared to SIBN. This indicates lower risk in terms of short-term price fluctuations for SYK.Check SIBN's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
SYK vs AVR Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, AVR has a market cap of 792.4M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while AVR trades at $8.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas AVR's P/E ratio is -4.20. In terms of profitability, SYK's ROE is +0.16%, compared to AVR's ROE of -0.78%. Regarding short-term risk, SYK is less volatile compared to AVR. This indicates lower risk in terms of short-term price fluctuations for SYK.Check AVR's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
SYK vs AHCO Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, AHCO has a market cap of 782.3M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while AHCO trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas AHCO's P/E ratio is 11.73. In terms of profitability, SYK's ROE is +0.16%, compared to AHCO's ROE of -0.15%. Regarding short-term risk, SYK is less volatile compared to AHCO. This indicates lower risk in terms of short-term price fluctuations for SYK.Check AHCO's competition here
Varex Imaging Corporation (NASDAQ: VREX)
SYK vs VREX Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, VREX has a market cap of 777.6M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while VREX trades at $18.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas VREX's P/E ratio is 19.44. In terms of profitability, SYK's ROE is +0.16%, compared to VREX's ROE of +0.05%. Regarding short-term risk, SYK is more volatile compared to VREX. This indicates higher risk in terms of short-term price fluctuations for SYK.Check VREX's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
SYK vs CTKB Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, CTKB has a market cap of 681.9M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while CTKB trades at $5.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas CTKB's P/E ratio is -27.97. In terms of profitability, SYK's ROE is +0.16%, compared to CTKB's ROE of -0.24%. Regarding short-term risk, SYK is less volatile compared to CTKB. This indicates lower risk in terms of short-term price fluctuations for SYK.Check CTKB's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
SYK vs SSII Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, SSII has a market cap of 658.4M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while SSII trades at $3.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas SSII's P/E ratio is -54.83. In terms of profitability, SYK's ROE is +0.16%, compared to SSII's ROE of -0.27%. Regarding short-term risk, SYK is less volatile compared to SSII. This indicates lower risk in terms of short-term price fluctuations for SYK.Check SSII's competition here
Surmodics, Inc. (NASDAQ: SRDX)
SYK vs SRDX Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas SRDX's P/E ratio is -34.66. In terms of profitability, SYK's ROE is +0.16%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, SYK is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for SYK.Check SRDX's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
SYK vs APEN Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas APEN's P/E ratio is -9.43. In terms of profitability, SYK's ROE is +0.16%, compared to APEN's ROE of -0.85%. Regarding short-term risk, SYK is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for SYK.Check APEN's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
SYK vs KIDS Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, KIDS has a market cap of 574.1M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while KIDS trades at $22.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas KIDS's P/E ratio is -18.94. In terms of profitability, SYK's ROE is +0.16%, compared to KIDS's ROE of -0.12%. Regarding short-term risk, SYK is less volatile compared to KIDS. This indicates lower risk in terms of short-term price fluctuations for SYK.Check KIDS's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
SYK vs DCTH Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, DCTH has a market cap of 556.1M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while DCTH trades at $16.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas DCTH's P/E ratio is 1611.00. In terms of profitability, SYK's ROE is +0.16%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, SYK is less volatile compared to DCTH. This indicates lower risk in terms of short-term price fluctuations for SYK.Check DCTH's competition here
ZimVie Inc. (NASDAQ: ZIMV)
SYK vs ZIMV Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, SYK's ROE is +0.16%, compared to ZIMV's ROE of -0.01%. Regarding short-term risk, SYK is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for SYK.Check ZIMV's competition here
Cerus Corporation (NASDAQ: CERS)
SYK vs CERS Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, CERS has a market cap of 515.9M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while CERS trades at $2.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas CERS's P/E ratio is -85.05. In terms of profitability, SYK's ROE is +0.16%, compared to CERS's ROE of -0.10%. Regarding short-term risk, SYK is less volatile compared to CERS. This indicates lower risk in terms of short-term price fluctuations for SYK.Check CERS's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
SYK vs TCMD Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, TCMD has a market cap of 515.4M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while TCMD trades at $22.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas TCMD's P/E ratio is 21.16. In terms of profitability, SYK's ROE is +0.16%, compared to TCMD's ROE of +0.11%. Regarding short-term risk, SYK is less volatile compared to TCMD. This indicates lower risk in terms of short-term price fluctuations for SYK.Check TCMD's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
SYK vs NPCE Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, NPCE has a market cap of 495.7M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while NPCE trades at $14.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas NPCE's P/E ratio is -25.51. In terms of profitability, SYK's ROE is +0.16%, compared to NPCE's ROE of -1.20%. Regarding short-term risk, SYK is less volatile compared to NPCE. This indicates lower risk in terms of short-term price fluctuations for SYK.Check NPCE's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
SYK vs SGHT Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, SGHT has a market cap of 461.9M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while SGHT trades at $8.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas SGHT's P/E ratio is -15.16. In terms of profitability, SYK's ROE is +0.16%, compared to SGHT's ROE of -0.51%. Regarding short-term risk, SYK is less volatile compared to SGHT. This indicates lower risk in terms of short-term price fluctuations for SYK.Check SGHT's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
SYK vs PACB Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, PACB has a market cap of 422.4M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while PACB trades at $1.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas PACB's P/E ratio is -3.32. In terms of profitability, SYK's ROE is +0.16%, compared to PACB's ROE of -49.62%. Regarding short-term risk, SYK is less volatile compared to PACB. This indicates lower risk in terms of short-term price fluctuations for SYK.Check PACB's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
SYK vs CLPT Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, CLPT has a market cap of 419M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while CLPT trades at $13.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas CLPT's P/E ratio is -11.84. In terms of profitability, SYK's ROE is +0.16%, compared to CLPT's ROE of -1.88%. Regarding short-term risk, SYK is less volatile compared to CLPT. This indicates lower risk in terms of short-term price fluctuations for SYK.Check CLPT's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
SYK vs SENS Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, SENS has a market cap of 408.7M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while SENS trades at $9.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas SENS's P/E ratio is -4.39. In terms of profitability, SYK's ROE is +0.16%, compared to SENS's ROE of -1.66%. Regarding short-term risk, SYK is less volatile compared to SENS. This indicates lower risk in terms of short-term price fluctuations for SYK.Check SENS's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
SYK vs OFIX Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, OFIX has a market cap of 361.8M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while OFIX trades at $8.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas OFIX's P/E ratio is -5.83. In terms of profitability, SYK's ROE is +0.16%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, SYK is less volatile compared to OFIX. This indicates lower risk in terms of short-term price fluctuations for SYK.Check OFIX's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
SYK vs CATX Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, CATX has a market cap of 338.1M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while CATX trades at $2.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas CATX's P/E ratio is -2.23. In terms of profitability, SYK's ROE is +0.16%, compared to CATX's ROE of -0.42%. Regarding short-term risk, SYK is less volatile compared to CATX. This indicates lower risk in terms of short-term price fluctuations for SYK.Check CATX's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
SYK vs SMLR Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas SMLR's P/E ratio is 3.92. In terms of profitability, SYK's ROE is +0.16%, compared to SMLR's ROE of +0.06%. Regarding short-term risk, SYK is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for SYK.Check SMLR's competition here
CapsoVision, Inc. (NASDAQ: CV)
SYK vs CV Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, CV has a market cap of 309.3M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while CV trades at $6.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas CV's P/E ratio is -9.83. In terms of profitability, SYK's ROE is +0.16%, compared to CV's ROE of -1.78%. Regarding short-term risk, SYK is less volatile compared to CV. This indicates lower risk in terms of short-term price fluctuations for SYK.Check CV's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
SYK vs TLSI Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, TLSI has a market cap of 306.6M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while TLSI trades at $4.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas TLSI's P/E ratio is -2.96. In terms of profitability, SYK's ROE is +0.16%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, SYK is less volatile compared to TLSI. This indicates lower risk in terms of short-term price fluctuations for SYK.Check TLSI's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
SYK vs TMCI Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, TMCI has a market cap of 290.6M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while TMCI trades at $4.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas TMCI's P/E ratio is -4.77. In terms of profitability, SYK's ROE is +0.16%, compared to TMCI's ROE of -0.74%. Regarding short-term risk, SYK is less volatile compared to TMCI. This indicates lower risk in terms of short-term price fluctuations for SYK.Check TMCI's competition here
Avita Medical Inc. (NASDAQ: RCEL)
SYK vs RCEL Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, RCEL has a market cap of 269.3M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while RCEL trades at $10.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas RCEL's P/E ratio is -7.53. In terms of profitability, SYK's ROE is +0.16%, compared to RCEL's ROE of +2.32%. Regarding short-term risk, SYK is less volatile compared to RCEL. This indicates lower risk in terms of short-term price fluctuations for SYK.Check RCEL's competition here
InfuSystem Holdings, Inc. (AMEX: INFU)
SYK vs INFU Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, INFU has a market cap of 258.3M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while INFU trades at $12.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas INFU's P/E ratio is 31.22. In terms of profitability, SYK's ROE is +0.16%, compared to INFU's ROE of +0.15%. Regarding short-term risk, SYK is less volatile compared to INFU. This indicates lower risk in terms of short-term price fluctuations for SYK.Check INFU's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
SYK vs MGRM Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas MGRM's P/E ratio is -12.00. In terms of profitability, SYK's ROE is +0.16%, compared to MGRM's ROE of -0.85%. Regarding short-term risk, SYK is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for SYK.Check MGRM's competition here
Electromed, Inc. (AMEX: ELMD)
SYK vs ELMD Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, ELMD has a market cap of 225.3M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while ELMD trades at $27.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas ELMD's P/E ratio is 20.77. In terms of profitability, SYK's ROE is +0.16%, compared to ELMD's ROE of +0.23%. Regarding short-term risk, SYK is less volatile compared to ELMD. This indicates lower risk in terms of short-term price fluctuations for SYK.Check ELMD's competition here
Nevro Corp. (NYSE: NVRO)
SYK vs NVRO Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas NVRO's P/E ratio is -1.91. In terms of profitability, SYK's ROE is +0.16%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, SYK is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for SYK.Check NVRO's competition here
Profound Medical Corp. (NASDAQ: PROF)
SYK vs PROF Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, PROF has a market cap of 221.7M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while PROF trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas PROF's P/E ratio is -6.22. In terms of profitability, SYK's ROE is +0.16%, compared to PROF's ROE of -0.56%. Regarding short-term risk, SYK is less volatile compared to PROF. This indicates lower risk in terms of short-term price fluctuations for SYK.Check PROF's competition here
RxSight, Inc. (NASDAQ: RXST)
SYK vs RXST Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, RXST has a market cap of 212.8M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while RXST trades at $5.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas RXST's P/E ratio is -4.55. In terms of profitability, SYK's ROE is +0.16%, compared to RXST's ROE of -0.17%. Regarding short-term risk, SYK is less volatile compared to RXST. This indicates lower risk in terms of short-term price fluctuations for SYK.Check RXST's competition here
Neuronetics, Inc. (NASDAQ: STIM)
SYK vs STIM Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, STIM has a market cap of 198.3M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while STIM trades at $2.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas STIM's P/E ratio is -6.48. In terms of profitability, SYK's ROE is +0.16%, compared to STIM's ROE of -1.51%. Regarding short-term risk, SYK is less volatile compared to STIM. This indicates lower risk in terms of short-term price fluctuations for SYK.Check STIM's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
SYK vs BSGM Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas BSGM's P/E ratio is -5.81. In terms of profitability, SYK's ROE is +0.16%, compared to BSGM's ROE of +15.26%. Regarding short-term risk, SYK is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for SYK.Check BSGM's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
SYK vs MDGS Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas MDGS's P/E ratio is -0.27. In terms of profitability, SYK's ROE is +0.16%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, SYK is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for SYK.Check MDGS's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
SYK vs QIPT Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas QIPT's P/E ratio is -15.87. In terms of profitability, SYK's ROE is +0.16%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, SYK is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for SYK.Check QIPT's competition here
Lucid Diagnostics Inc. (NASDAQ: LUCD)
SYK vs LUCD Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, LUCD has a market cap of 161.2M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while LUCD trades at $0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas LUCD's P/E ratio is -2.28. In terms of profitability, SYK's ROE is +0.16%, compared to LUCD's ROE of -4.04%. Regarding short-term risk, SYK is less volatile compared to LUCD. This indicates lower risk in terms of short-term price fluctuations for SYK.Check LUCD's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
SYK vs FOCL Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, FOCL has a market cap of 158.9M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while FOCL trades at $4.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas FOCL's P/E ratio is -4.10. In terms of profitability, SYK's ROE is +0.16%, compared to FOCL's ROE of -2.90%. Regarding short-term risk, SYK is less volatile compared to FOCL. This indicates lower risk in terms of short-term price fluctuations for SYK.Check FOCL's competition here
Quantum-Si incorporated (NASDAQ: QSI)
SYK vs QSI Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, QSI has a market cap of 149.5M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while QSI trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas QSI's P/E ratio is -1.64. In terms of profitability, SYK's ROE is +0.16%, compared to QSI's ROE of -0.47%. Regarding short-term risk, SYK is less volatile compared to QSI. This indicates lower risk in terms of short-term price fluctuations for SYK.Check QSI's competition here
Quanterix Corporation (NASDAQ: QTRX)
SYK vs QTRX Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, QTRX has a market cap of 143.2M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while QTRX trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas QTRX's P/E ratio is -1.20. In terms of profitability, SYK's ROE is +0.16%, compared to QTRX's ROE of -0.44%. Regarding short-term risk, SYK is less volatile compared to QTRX. This indicates lower risk in terms of short-term price fluctuations for SYK.Check QTRX's competition here
Inogen, Inc. (NASDAQ: INGN)
SYK vs INGN Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, INGN has a market cap of 138.1M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while INGN trades at $5.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas INGN's P/E ratio is -5.60. In terms of profitability, SYK's ROE is +0.16%, compared to INGN's ROE of -0.13%. Regarding short-term risk, SYK is less volatile compared to INGN. This indicates lower risk in terms of short-term price fluctuations for SYK.Check INGN's competition here
electroCore, Inc. (NASDAQ: ECOR)
SYK vs ECOR Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, ECOR has a market cap of 108.1M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while ECOR trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas ECOR's P/E ratio is -7.14. In terms of profitability, SYK's ROE is +0.16%, compared to ECOR's ROE of +5.25%. Regarding short-term risk, SYK is less volatile compared to ECOR. This indicates lower risk in terms of short-term price fluctuations for SYK.Check ECOR's competition here
iCAD, Inc. (NASDAQ: ICAD)
SYK vs ICAD Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas ICAD's P/E ratio is -20.37. In terms of profitability, SYK's ROE is +0.16%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, SYK is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for SYK.Check ICAD's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
SYK vs HJLI Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas HJLI's P/E ratio is N/A. In terms of profitability, SYK's ROE is +0.16%, compared to HJLI's ROE of -0.62%. Regarding short-term risk, SYK is less volatile compared to HJLI. This indicates lower risk in terms of short-term price fluctuations for SYK.Check HJLI's competition here
Asensus Surgical, Inc. (AMEX: ASXC)
SYK vs ASXC Comparison September 2026
Stryker Corporation (NYSE: SYK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SYK stands at 105.1B. In comparison, ASXC has a market cap of 94.9M. Regarding current trading prices, SYK is priced at $274.19 on the NYSE, while ASXC trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SYK currently has a P/E ratio of 20.47, whereas ASXC's P/E ratio is -1.12. In terms of profitability, SYK's ROE is +0.16%, compared to ASXC's ROE of -1.18%. Regarding short-term risk, SYK is more volatile compared to ASXC. This indicates higher risk in terms of short-term price fluctuations for SYK.Check ASXC's competition here